Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome

  Free Subscription


29.10.2018

1 Adv Drug Deliv Rev
1 Adv Neurobiol
1 Adv Ther
1 Am J Physiol Gastrointest Liver Physiol
1 Biochim Biophys Acta Mol Cell Res
1 BMJ Open
1 Br J Pharmacol
1 Clin Lab
1 Cureus
1 Curr Opin Gastroenterol
1 FASEB J
4 Gastroenterol Clin North Am
1 Gastroenterol Hepatol (N Y)
1 Gastroenterology Res
5 J Neurogastroenterol Motil
1 Korean J Fam Med
1 Mol Cell Endocrinol
1 Neurogastroenterol Motil
1 Pediatr Gastroenterol Hepatol Nutr
1 PLoS One
1 World J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Drug Deliv Rev

  1. BAK A, Ashford M, Brayden DJ
    Local delivery of macromolecules to treat diseases associated with the colon.
    Adv Drug Deliv Rev. 2018 Oct 22. pii: S0169-409X(18)30259.
    PubMed     Text format     Abstract available


    Adv Neurobiol

  2. LI Y
    Synaptic Plasticity and Synchrony in the Anterior Cingulate Cortex Circuitry: A Neural Network Approach to Causality of Chronic Visceral Pain and Associated Cognitive Deficits.
    Adv Neurobiol. 2018;21:219-245.
    PubMed     Text format     Abstract available


    Adv Ther

  3. PORIKA SK, Veligandla KC, Muni SK, Acharya S, et al
    Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Adv Ther. 2018 Oct 22. pii: 10.1007/s12325-018-0814.
    PubMed     Text format     Abstract available


    Am J Physiol Gastrointest Liver Physiol

  4. EL-AYACHE N, Galligan JJ
    5-HT3 receptor signaling in serotonin transporter knockout rats: a female sex specific animal model of visceral hypersensitivity.
    Am J Physiol Gastrointest Liver Physiol. 2018.
    PubMed     Text format     Abstract available


    Biochim Biophys Acta Mol Cell Res

  5. FETTUCCIARI K, Macchioni L, Davidescu M, Scarpelli P, et al
    Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis.
    Biochim Biophys Acta Mol Cell Res. 2018;1865:1945-1958.
    PubMed     Text format     Abstract available


    BMJ Open

  6. DONG Y, Berens S, Eich W, Schaefert R, et al
    Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study.
    BMJ Open. 2018;8:e019453.
    PubMed     Text format     Abstract available


    Br J Pharmacol

  7. WALLACE JL
    Nitric Oxide in the Gastrointestinal Tract: Opportunities for Drug Development.
    Br J Pharmacol. 2018 Oct 24. doi: 10.1111/bph.14527.
    PubMed     Text format     Abstract available


    Clin Lab

  8. DOLLINGER MM, Behl S, Fleig WE
    Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Clin Lab. 2018;64:1719-1730.
    PubMed     Text format     Abstract available


    Cureus

  9. MUDYANADZO TA, Hauzaree C, Yerokhina O, Architha NN, et al
    Irritable Bowel Syndrome and Depression: A Shared Pathogenesis.
    Cureus. 2018;10:e3178.
    PubMed     Text format     Abstract available


    Curr Opin Gastroenterol

  10. DAYANANDA P, Wilcox MH
    Irritable bowel syndrome following Clostridium difficile infection.
    Curr Opin Gastroenterol. 2018 Oct 17. doi: 10.1097/MOG.0000000000000490.
    PubMed     Text format     Abstract available


    FASEB J

  11. READE S, Williams JM, Aggio R, Duckworth CA, et al
    Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.
    FASEB J. 2018 Oct 25:fj201800076RR. doi: 10.1096/fj.201800076.
    PubMed     Text format     Abstract available


    Gastroenterol Clin North Am

  12. VAN TILBURG MAL, Carter CA
    Integration of Biomedical and Psychosocial Treatments in Pediatrics Functional Gastrointestinal Disorders.
    Gastroenterol Clin North Am. 2018;47:863-875.
    PubMed     Text format     Abstract available

  13. CHUMPITAZI BP
    Update on Dietary Management of Childhood Functional Abdominal Pain Disorders.
    Gastroenterol Clin North Am. 2018;47:715-726.
    PubMed     Text format     Abstract available

  14. FLOCH MH
    The Role of Prebiotics and Probiotics in Gastrointestinal Disease.
    Gastroenterol Clin North Am. 2018;47:179-191.
    PubMed     Text format     Abstract available

  15. KHLEVNER J, Park Y, Margolis KG
    Brain-Gut Axis: Clinical Implications.
    Gastroenterol Clin North Am. 2018;47:727-739.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol (N Y)

  16. NGUYEN L
    Complementary and Alternative Medicine for the Management of Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2018;14:536-538.
    PubMed     Text format    


    Gastroenterology Res

  17. NASSAR Y, Richter S
    Gastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors.
    Gastroenterology Res. 2018;11:340-345.
    PubMed     Text format     Abstract available


    J Neurogastroenterol Motil

  18. LIN MJ, Yu BP
    Role of High-affinity Choline Transporter 1 in Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:643-655.
    PubMed     Text format     Abstract available

  19. KIM HJ
    Do Toll-like Receptors Play a New Role as a Biomarker of Irritable Bowel Syndrome?
    J Neurogastroenterol Motil. 2018;24:510-511.
    PubMed     Text format    

  20. KIM YS, Kim N
    Sex-Gender Differences in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:544-558.
    PubMed     Text format     Abstract available

  21. SHUKLA R, Ghoshal U, Ranjan P, Ghoshal UC, et al
    Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis.
    J Neurogastroenterol Motil. 2018;24:628-642.
    PubMed     Text format     Abstract available

  22. HOU Q, Huang Y, Zhang C, Zhu S, et al
    MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats.
    J Neurogastroenterol Motil. 2018;24:656-668.
    PubMed     Text format     Abstract available


    Korean J Fam Med

  23. LEE SH, Cho DY, Lee SH, Han KS, et al
    A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue.
    Korean J Fam Med. 2018 Oct 26. pii: kjfm.17.0064. doi: 10.4082/kjfm.17.0064.
    PubMed     Text format     Abstract available


    Mol Cell Endocrinol

  24. HETTERICH L, Mack I, Giel KE, Zipfel S, et al
    An update on gastrointestinal disturbances in eating disorders.
    Mol Cell Endocrinol. 2018 Oct 22. pii: S0303-7207(18)30311.
    PubMed     Text format     Abstract available


    Neurogastroenterol Motil

  25. FARMER AD, Ruffle JK, Hobson AR
    Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation.
    Neurogastroenterol Motil. 2018 Oct 23:e13492. doi: 10.1111/nmo.13492.
    PubMed     Text format     Abstract available


    Pediatr Gastroenterol Hepatol Nutr

  26. TRIVIC I, Hojsak I
    Initial Diagnosis of Functional Gastrointestinal Disorders in Children Increases a Chance for Resolution of Symptoms.
    Pediatr Gastroenterol Hepatol Nutr. 2018;21:264-270.
    PubMed     Text format     Abstract available


    PLoS One

  27. SADEGHIAN M, Sadeghi O, Hassanzadeh Keshteli A, Daghaghzadeh H, et al
    Physical activity in relation to irritable bowel syndrome among Iranian adults.
    PLoS One. 2018;13:e0205806.
    PubMed     Text format     Abstract available


    World J Gastroenterol

  28. CODONER-FRANCH P, Gombert M
    Circadian rhythms in the pathogenesis of gastrointestinal diseases.
    World J Gastroenterol. 2018;24:4297-4303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: